{"database": "lobbying", "table": "lobbying_activities", "rows": [[827624, "c617db9d-33e8-473b-bc21-03a88467d2cc", "Q3", "THE UNITED STATES PHARMACOPEIAL CONVENTION", 400358632, "THE UNITED STATES PHARMACOPEIAL CONVENTION", 2009, "third_quarter", "PHA", "- HR 1859, \"Independent Drug Education & Outreach Act\", regarding all provisions as a neutral, expert scientific resource.\n- S 726, \"Promoting Innovation and Access to Lifesaving Medicine Act, regarding all provisions.\n- Issues relating to heparin. - Information regarding USP General Chapter <1> Injections - labeling on ferrules and cap overseals, specifically to update Congress on USP standards.\n- Information on follow-on biologics.\n- Information on drug quality as a neutral, expert scientific resource.", "Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", null, 90000, 0, 0, "2009-10-14T16:57:17-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["827624"], "units": {}, "query_ms": 4.850003984756768, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}